1. Ye, Hui, Ding, XuChao, Lv, XinRan, Li, RuoNan, Cao, LiLi. 2024. KLF14 directly downregulates the expression of GPX4 to exert antitumor effects by promoting ferroptosis in cervical cancer. In Journal of translational medicine, 22, 923. doi:10.1186/s12967-024-05714-6. https://pubmed.ncbi.nlm.nih.gov/39390559/
2. Wang, Lu, Tong, Xin, Gu, Fang, Chang, Yongsheng, Zhang, Huabing. 2017. The KLF14 transcription factor regulates hepatic gluconeogenesis in mice. In The Journal of biological chemistry, 292, 21631-21642. doi:10.1074/jbc.RA117.000184. https://pubmed.ncbi.nlm.nih.gov/29123026/
3. Iwaya, Chihiro, Kitajima, Hidetoshi, Yamamoto, Ken, Shibata, Hiroki, Inoguchi, Toyoshi. 2018. DNA methylation of the Klf14 gene region in whole blood cells provides prediction for the chronic inflammation in the adipose tissue. In Biochemical and biophysical research communications, 497, 908-915. doi:10.1016/j.bbrc.2017.12.104. https://pubmed.ncbi.nlm.nih.gov/29425818/
4. Du, Zhipeng, Liu, Mei, Wang, Zhihui, Tian, Dean, Xia, Limin. 2021. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ. In Cell proliferation, 54, e13072. doi:10.1111/cpr.13072. https://pubmed.ncbi.nlm.nih.gov/34031939/